Alkermes (ALKS) Other Operating Expenses (2010 - 2026)
Alkermes (ALKS) posted quarterly Other Operating Expenses of $105.7 million for Q2 2026, up 1768.56% year-over-year from $5.7 million in Q2 2025, and up 402.34% quarter-over-quarter from $21.0 million in Q1 2026.
Alkermes (ALKS) Other Operating Expenses (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Other Operating Expenses for 17 consecutive years, with $105.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Operating Expenses rose 1768.56% year-over-year to $105.7 million; the TTM figure through Jun 2026 stood at $163.4 million (up 254.29% YoY), while the FY2025 annual figure was $40.4 million, down 11.27% from the prior year.
- Other Operating Expenses rose to $105.7 million in Q2 2026 per ALKS's latest filing, from $21.0 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $105.7 million in Q2 2026 and bottomed at -$140.2 million in Q4 2023.
- Historically, Other Operating Expenses has averaged $15.3 million across 5 years, with a median of $17.7 million in 2025.
- Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 1591.94% — and 2023, when it surged 8192.76%.
- Alkermes' Other Operating Expenses stood at -$3.6 million in 2022, then sank by 3846.69% to -$140.2 million in 2023, then jumped by 115.27% to $21.4 million in 2024, then retreated by 11.4% to $19.0 million in 2025, then surged by 456.85% to $105.7 million in 2026.
- Business Quant data shows ALKS's Other Operating Expenses at $105.7 million in Q2 2026, $21.0 million in Q1 2026, and $19.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 105.67 Mn |
| Mar 31, 2026 | 21.04 Mn |
| Dec 31, 2025 | 18.98 Mn |
| Sep 30, 2025 | 17.70 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | -1.92 Mn |
| Dec 31, 2024 | 21.42 Mn |
| Sep 30, 2024 | 20.96 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | -140.23 Mn |
| Sep 30, 2023 | 70.49 Mn |
| Jun 30, 2023 | 72.15 Mn |
| Mar 31, 2023 | 66.96 Mn |
| Sep 30, 2022 | -3.55 Mn |
| Jun 30, 2022 | 870,000.00 |
| Mar 31, 2022 | -19.07 Mn |
| Dec 31, 2021 | -750,000.00 |
| Sep 30, 2021 | -5.20 Mn |
| Jun 30, 2021 | 3.24 Mn |